Penny stock player to review all options to try staying afloat after clinical trial fail
Adamis Pharmaceuticals is slowly tumbling down, and the biotech is looking at all its options. After ...
Read moreAdamis Pharmaceuticals is slowly tumbling down, and the biotech is looking at all its options. After ...
Read moreTwitter (TWTR) saw its stock advance in Wednesday's intraday action, bolstered by some seemingly positive developments ...
Read moreThe mere handful of biotechs stocks that are in positive territory this year offer clues as ...
Read moreBy M. Marin NASDAQ:QNRX READ THE FULL QNRX RESEARCH REPORT FDA Clearance - Moving QRX003 forward ...
Read moreEver since Medicare proposed to sharply limit coverage of the controversial Alzheimer’s drug Aduhelm, the agency ...
Read moreShares of Vertex Pharmaceuticals Inc. VRTX, +1.33% rose 1.33% to $222.53 Monday, on what proved to ...
Read moreDUBLIN, Jan. 7, 2022 /PRNewswire/ -- The "Cancer Clinical Decision Tools Global Market Report 2021: COVID-19 ...
Read moreText size Theranos founder and former CEO Elizabeth Holmes. Justin Sullivan/Getty Images A federal jury in ...
Read moreContext Therapeutics (NASDAQ:CNTX) stock is rising higher on Friday thanks to results from a Phase 0 ...
Read more© 2022 TheDailyStock.News